Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 2, 2016, Pages 308-316

  Duval, Cédric ^a   Ali, Majid ^a   Chaudhry, Waleed W ^a   Ridger, Victoria C ^b   Ariëns, Robert A S ^a   Philippou, Helen ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

factor XIII; fibrinogen; mutation; thrombin; venous thrombosis

Indexed keywords

ALANINE; BLOOD CLOTTING FACTOR 13 A SUBUNIT V34L VARIANT; BLOOD CLOTTING FACTOR 13A; GLYCINE; UNCLASSIFIED DRUG; FIBRIN; RECOMBINANT PROTEIN; THROMBIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; FIBRIN CLOT; FIBRIN POLYMERIZATION; IN VITRO STUDY; MOUSE; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; THROMBOSIS; 129 MOUSE; ANIMAL; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TEST; CBA MOUSE; DISEASE MODEL; GENETICS; GENOTYPE; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MUTATION; PHENOTYPE; TIME FACTOR; VEIN THROMBOSIS;

AMINO ACID SUBSTITUTION; ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; DISEASE MODELS, ANIMAL; FACTOR XIII DEFICIENCY; FACTOR XIIIA; FIBRIN; GENOTYPE; HUMANS; MALE; MICE, 129 STRAIN; MICE, INBRED CBA; MICE, KNOCKOUT; MUTATION; PHENOTYPE; RECOMBINANT PROTEINS; THROMBIN; TIME FACTORS; VENOUS THROMBOSIS;

EID: 84955670895     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306695     Document Type: Article

References (43)

1. Schwartz ML, Pizzo SV, Sullivan JB, Hill RL, McKee PA, A comparative study of crosslinked and noncrosslinked fibrin from the major classes of vertebrates. Thromb Diath Haemorrh 1973 29 313 338
2. Lorand L, Activation of blood coagulation factor XIII. Ann N Y Acad Sci 1986 485 144 158
3. Chen R, Doolittle RF,-cross-linking sites in human and bovine fibrin. Biochemistry 1971 10 4487 4491
4. Cottrell BA, Strong DD, Watt KW, Doolittle RF, Amino acid sequence studies on the alpha chain of human fibrinogen. Exact location of cross-linking acceptor sites. Biochemistry 1979 18 5405 5410
5. Sakata Y, Aoki N, Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest 1980 65 290 297. doi: 10.1172/JCI109671.
6. Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RA, Seifried E, Oldenburg J, International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007 97 914 921
7. Inbal A, Muszbek L, Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost 2003 29 171 174. doi: 10.1055/s-2003-38832.
8. Inbal A, Lubetsky A, Krapp T, Castel D, Shaish A, Dickneitte G, Modis L, Muszbek L, Inbal A, Impaired wound healing in factor XIII deficient mice. Thromb Haemost 2005 94 432 437. doi: 10.1267/THRO05020432.
9. Anwar R, Gallivan L, Edmonds SD, Markham AF, Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 1999 93 897 905
10. Chen F, Qiao Q, Xu P, Fan B, Chen Z, Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: a meta-analysis. Clin Appl Thromb Hemost 2014 20 783 792. doi: 10.1177/1076029613504130.
11. Vokó Z, Bereczky Z, Katona E, Adány R, Muszbek L, Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis. Thromb Haemost 2007 97 458 463
12. Wells PS, Anderson JL, Scarvelis DK, Doucette SP, Gagnon F, Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol 2006 164 101 109. doi: 10.1093/aje/kwj179.
13. Ariëns RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ, The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000 96 988 995
14. Lim BC, Ariëns RA, Carter AM, Weisel JW, Grant PJ, Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet 2003 361 1424 1431. doi: 10.1016/S0140-6736(03)13135-2.
15. Balogh I, Szôke G, Kárpáti L, Wartiovaara U, Katona E, Komáromi I, Haramura G, Pfliegler G, Mikkola H, Muszbek L, Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 2000 96 2479 2486
16. Wartiovaara U, Mikkola H, Szôke G, Haramura G, Kárpáti L, Balogh I, Lassila R, Muszbek L, Palotie A, Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost 2000 84 595 600
17. Trumbo TA, Maurer MC, Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation. J Biol Chem 2000 275 20627 20631. doi: 10.1074/jbc.M000209200.
18. Trumbo TA, Maurer MC, Thrombin hydrolysis of V29F and V34L mutants of factor XIII (28-41) reveals roles of the P(9) and P(4) positions in factor XIII activation. Biochemistry 2002 41 2859 2868
19. Trumbo TA, Maurer MC, V34I and V34A substitutions within the factor XIII activation peptide segment (28-41) affect interactions with the thrombin active site. Thromb Haemost 2003 89 647 653. doi: 10.1267/THRO03040647.
20. Weisel JW, Nagaswami C, Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 1992 63 111 128. doi: 10.1016/S0006-3495(92)81594-1.
21. Gabriel DA, Muga K, Boothroyd EM, The effect of fibrin structure on fibrinolysis. J Biol Chem 1992 267 24259 24263
22. Carr ME Jr, Alving BM, Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul Fibrinolysis 1995 6 567 573
23. Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW, Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 2000 20 1354 1361
24. Kohler HP, Ariëns RA, Whitaker P, Grant PJ, A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 1998 80 704
25. Ali M, Ridger VC, Pease RJ, Howells G, Grant PJ, Ariens RA, Philippou H, Establishment of method and image analysis systems to monitor clot formation and FXIII activity in real time using a murine in vivo model of thrombosis. J Thromb Haemost 2012 10 E14 E15
26. Chernysh IN, Nagaswami C, Purohit PK, Weisel JW, Fibrin clots are equilibrium polymers that can be remodeled without proteolytic digestion. Sci Rep 2012 2 879. doi: 10.1038/srep00879.
27. Schroeder V, Kohler HP, New developments in the area of factor XIII. J Thromb Haemost 2013 11 234 244. doi: 10.1111/jth.12074.
28. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ, Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998 79 8 13
29. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ, Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005 46 937 954. doi: 10.1016/j.jacc.2005.03.074.
30. Bini A, Fenoglio JJ Jr, Mesa-Tejada R, Kudryk B, Kaplan KL, Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 1989 9 109 121
31. Shekhonin BV, Domogatsky SP, Idelson GL, Koteliansky VE, Rukosuev VS, Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. Atherosclerosis 1987 67 9 16
32. Rekhter MD, Zhang K, Narayanan AS, Phan S, Schork MA, Gordon D, Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am J Pathol 1993 143 1634 1648
33. Dufourcq P, Louis H, Moreau C, Daret D, Boisseau MR, Lamazière JM, Bonnet J, Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol 1998 18 168 176
34. Mosher DF, Schad PE, Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. J Clin Invest 1979 64 781 787. doi: 10.1172/JCI109524.
35. Mosher DF, Schad PE, Vann JM, Cross-linking of collagen and fibronectin by factor XIIIa. Localization of participating glutaminyl residues to a tryptic fragment of fibronectin. J Biol Chem 1980 255 1181 1188
36. Sane DC, Moser TL, Pippen AM, Parker CJ, Achyuthan KE, Greenberg CS, Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun 1988 157 115 120
37. Skorstengaard K, Halkier T, Højrup P, Mosher D, Sequence location of a putative transglutaminase cross-linking site in human vitronectin. FEBS Lett 1990 262 269 274
38. Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ, Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999 93 906 908
39. Van Hylckama Vlieg A, Komanasin N, Ariëns RA, Poort SR, Grant PJ, Bertina RM, Rosendaal FR, Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Br J Haematol 2002 119 169 175
40. Salazar-Sánchez L, Leon MP, Cartin M, Schuster G, Wulff K, Schröder W, Jiménez-Arce G, Chacon R, Herrmann FH, The FXIIIVal34Leu, common and risk factors of venous thrombosis in early middle-age Costa Rican patients. Cell Biochem Funct 2007 25 739 745. doi: 10.1002/cbf.1389.
41. Corral J, González-Conejero R, Iniesta JA, Rivera J, Martínez C, Vicente V, The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 2000 85 293 297
42. Tiedje V, Dunkler D, Ay C, Horvath B, Quehenberger P, Pabinger M, Zielinski C, Pabinger I, Mannhalter C, The role of fibrinogen plasma levels, the-455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis. Thromb Haemost 2011 106 908 913. doi: 10.1160/TH11-04-0278.
43. Reitsma PH, Versteeg HH, Middeldorp S, Mechanistic view of risk factors for venous thromboembolism. Arterioscler Thromb Vasc Biol 2012 32 563 568. doi: 10.1161/ATVBAHA.111.242818.